Todorovska Nadica, Karadjova Irina, Arpadjan Sonja, Stafilov Trajce
Institute of Preventive Medical Care and Toxicology, Military Health Institution Center, 1000 Skopje, Macedonia.
Acta Pharm. 2003 Jun;53(2):83-90.
Problems and possibilities of the determination of Co in serum and urine samples by electrothermal atomic absorption spectrometry (ETAAS) are described. Optimal instrumental parameters as well as a suitable atomizer, calibration procedure and hydrogen peroxide as modifier are proposed for direct ETAAS measurement of Co in serum and urine. The detection limit achieved was 0.1 microg L(-1) for both matrices and relative standard deviations varied in the range 5-20% depending on the Co concentration in the sample. Validity of the method was verified by the analyses of standard reference materials. For serum samples with a Co content lower than the detection limit, a separation and preconcentration procedure based on liquid/liquid extraction is suggested prior to determination of Co in the organic phase by ETAAS. This procedure permits determination of 0.02 microg L(-1) Co in serum samples with a relative standard deviation of 10-18%.
描述了用电热原子吸收光谱法(ETAAS)测定血清和尿液样品中钴的问题与可能性。提出了用于血清和尿液中钴直接ETAAS测量的最佳仪器参数以及合适的原子化器、校准程序和作为基体改进剂的过氧化氢。两种基体的检测限均达到0.1μg L⁻¹,相对标准偏差根据样品中的钴浓度在5%至20%范围内变化。通过对标准参考物质的分析验证了该方法的有效性。对于钴含量低于检测限的血清样品,建议在通过ETAAS测定有机相中钴之前,采用基于液/液萃取的分离和预富集程序。该程序允许测定血清样品中0.02μg L⁻¹的钴,相对标准偏差为10%至18%。